Hi Tom - I was watching CHIR a few years ago [in the teens] but lost interest. Subsequently, I was entangled in the falling R2K! So, I missed CHIR until now.
Incidentally, I bought 5 biotech/drug stocks today, AZA, CHIR, MEDI, JNJ and CEGE and I thought CHIR would have the least visibility. As it turns out, she is by far the best of the bunch [bot @47]
I think there is a bit of froth in the biotech sector, even though some of the stories warrant the sky hi valuations. CHIR seems to me is a solid growth stock with tremendous value. I am surprised Novartis hasn't swallowed her whole before her valuation is comparable to her peers best, Bosco |